Opals
Gemstones
Jewelry
Coins
您尚未參與本次拍賣。
Natural 12.35 Carat Top Quality Swiss Blue AAA Grad Topaz
- 存貨單位
- 尺寸（毫米）
- 16.000 x 11.800 x 8.500mm
- 重量 (cts)
- 12.350
- Treatment
- No Treatment
- Clarity
- VVS
- 類型
- Faceted
- Shape
- Fancy, Oval
- 顏色
-
Blue Topaz
Blue Topaz is a brilliant blue colored, semi-precious gemstone from the Topaz mineral family. It comes in a wide range of colors including subtle sky blue to the intense inky blue. In vedic astrology, this gemstone is recommended as the astrological substitute of the precious Blue Sapphire and is worn to gain financial stability, fame, self-confidence and good health.
- 存貨單位
- 尺寸（毫米）
- 16.000 x 11.800 x 8.500 mm
- 重量 (cts)
- 12.350
- Treatment
- No Treatment
- Clarity
- VVS
- 類型
- Faceted
- Shape
- Fancy, Oval
- 顏色
-
Blue Topaz
Blue Topaz is a brilliant blue colored, semi-precious gemstone from the Topaz mineral family. It comes in a wide range of colors including subtle sky blue to the intense inky blue. In vedic astrology, this gemstone is recommended as the astrological substitute of the precious Blue Sapphire and is worn to gain financial stability, fame, self-confidence and good health.
| 運輸商 | 運送至：國家 | 運送到世界其他地區 |
|---|---|---|
| Standard Shipping - Tracked | $15.00 / ：幾天天 | $15.00 / ：幾天天 |
|
：國家
Standard Shipping - Tracked訂單折扣為$20.00 2或更多商品
世界其他地區
Standard Shipping - Tracked訂單折扣為$15.00 2或更多商品
|
||
| FedEx | $20.00 / ：幾天天 | $30.00 / ：幾天天 |
|
：國家
FedEx訂單折扣為$30.00 2或更多商品
世界其他地區
FedEx訂單折扣為$30.00 2或更多商品
|
||
-
消極的I sent this back because the color of the stone did not in my opinion match the color in the photo.
-
積極的
Paid and shipped - no feedback left after 100 days
-
積極的
Paid and shipped - no feedback left after 100 days
-
積極的
Thank you. Very happy with this gem.
為什麼用戶出價高於自己？
出價時，這是一個人願意為產品出價的最高金額。然後，我們的系統將自動代表投標人出價，逐步將出價提高到最高價，以保持其最高出價者的地位。
當出現「自動出價」圖示時，表示我們的系統正在根據投標者的最高出價主動為其出價。這可能看起來好像出價者出價高於自己，但這只是系統更新出價以反映出價者最高限額的結果。
審計
-
描述不准確
-
圖片準確
Comments
As per Listing Guide, Blue Topaz should be listed as treatment = irradiated. Buyer to confirm with seller on validity of no treatment.
